Home » Topics » Regulatory

Regulatory
RSS

Once-weekly Enbrel approved

Oct. 23, 2003

Lexiva, the only protease inhibitor offering flexible dosing, approved in U.S.

Oct. 22, 2003

Paxil CR approved for social anxiety disorder

Oct. 22, 2003

FDA accepts for filing NDA for ultra-low-dose transdermal estrogen patch

Oct. 20, 2003

PEG-Intron Redipen approved by FDA

Oct. 15, 2003

Betaseron prefilled diluent syringe receives FDA approval

Oct. 15, 2003

Seroquel approved in Europe for bipolar mania

Oct. 15, 2003

Approval for prefilled syringe presentation of Ovidrel

Oct. 14, 2003

Inspra approved for congestive heart failure in heart attack patients

Oct. 13, 2003

Abbott seeks approval for Humira for improvement of physical function in RA

Oct. 6, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...